发明授权
US07560450B2 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
有权
黄嘌呤衍生物，其制备及其作为药物组合物的用途
- 专利标题： Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
- 专利标题（中）： 黄嘌呤衍生物，其制备及其作为药物组合物的用途
-
申请号： US10716141申请日： 2003-11-18
-
公开(公告)号： US07560450B2公开(公告)日： 2009-07-14
- 发明人: Matthias Eckhardt , Frank Himmelsbach , Elke Langkopf , Roland Maier , Michael Mark , Mohammad Tadayyon
- 申请人： Matthias Eckhardt , Frank Himmelsbach , Elke Langkopf , Roland Maier , Michael Mark , Mohammad Tadayyon
- 申请人地址： DE Ingelheim
- 专利权人： Boehringer Ingelheim Pharma GmbH & Co., KG
- 当前专利权人： Boehringer Ingelheim Pharma GmbH & Co., KG
- 当前专利权人地址： DE Ingelheim
- 代理商 Michael P. Morris; Mary-Ellen M. Devlin; David L. Kershner
- 优先权： DE10254304 20021121
- 主分类号： C07D473/06
- IPC分类号： C07D473/06 ; A61K31/522 ; A61P3/10 ; A61P3/04
摘要：
The present invention relates to substituted xanthines of general formula the tautomers, the stereoisomers, the mixtures thereof, the prodrugs thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibitory effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
公开/授权文献
信息查询
